Search Results

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Nordson Corporation reported results for the fiscal second quarter ended April 30, 2023. Sales were $650 million, a 2% increase compared to the prior year’s second quarter sales of $635 million.

Nordson Corporation announced it will release third quarter fiscal year 2022 earnings on August 22, 2022 after the close of the market.

Nordson Corporation announced the recent appointments of Dr. John DeFord, executive vice president and chief technology officer of Becton, Dickinson and Company, and Ms. Jennifer Parmentier, vice president and president – Motion Systems Group for Parker Hannifin Corporation, to its board of directors.

Qosina is pleased to announce that it has entered into a distribution agreement with Nordson MEDICAL, a premier manufacturer and supplier of components to the bioprocess and medical device industries.

Nordson Corporation has acquired Fluortek, Inc., an Easton, Pennsylvania based precision plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry.

Nordson Corporation and the Nordson Corporation Foundation announced that they have contributed a combined $10 million to charity during the fiscal year ended October 31, 2018.

Feb. 11, 2020 13:30 UTC WESTLAKE, Ohio--( BUSINESS WIRE )-- Nordson Corporation (Nasdaq:NDSN) today announced that its board of directors declared a second quarter 2020 cash dividend in the amount of $0.38 per common share, payable on March 10, 2020 to shareholders of record as of the close of business on February 25, 2020. This amount equals the $0.38 per common share dividend paid in the first quarter of fiscal year 2020. Nordson Corporation engineers, manufact

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.